Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

NCT03547297 is registered in ClinicalTrials.gov with Alnylam Pharmaceuticals as lead sponsor.

NCT NCT03547297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03547297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Lead sponsor
Alnylam Pharmaceuticals
Phase
Observational
Overall status
Terminated
Start date
May 29, 2018
Completion date
January 15, 2019
Enrollment
212 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

acute hepatic porphyria, acute intermittent porphyria (aip), ala dehydratase deficient porphyria (adp), hepatic porphyrias, hereditary coproporphyria (hcp), porphyria acute, variegate porphyria (vp)